Mesenchymal stem cells to treat type 1 diabetes.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 05 07 2018
accepted: 26 10 2018
pubmed: 7 12 2018
medline: 4 8 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

What is clear is we are in the era of the stem cell and its potential in ameliorating human disease. Our perspective is generated from an in vivo model in a large animal that offers significant advantages (complete transplantation tolerance, large size and long life span). This review is an effort to meld our preclinical observations with others for the reader and to outline potential avenues to improve the present outlook for patients with diabetes. This effort exams the history or background of stem cell research in the laboratory and the clinic, types of stem cells, pluripotency or lack thereof based on a variety of pre-clinical investigations attempting endocrine pancreas recovery using stem cell transplantation. The focus is on the use of hematopoietic and mesenchymal stem cells. This review will also examine recent clinical experience following stem cell transplantation in patients with type 1 diabetes.

Identifiants

pubmed: 30508575
pii: S0925-4439(18)30436-8
doi: 10.1016/j.bbadis.2018.10.033
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165315

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

John S Pixley (JS)

Division of Rheumatology/Immunology, Department of Medicine, Texas Tech University Health Science Center, 3601 4th Street, MS 9410, Lubbock, TX 79430, USA. Electronic address: john.pixley@ttuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH